Cas no 409346-72-1 (N,4-dimethoxy-N-methylcyclohexanecarboxamide)
N,4-dimethoxy-N-methylcyclohexanecarboxamide Chemical and Physical Properties
Names and Identifiers
-
- N,4-dimethoxy-N-methylcyclohexanecarboxamide
- N,4-DIMETHOXY-N-METHYLCYCLOHEXANE-1-CARBOXAMIDE
- KFOOJJKZYIONCR-KYZUINATSA-N
- AKOS015964180
- AT39840
- Cyclohexanecarboxamide, N,4-dimethoxy-N-methyl-
- SCHEMBL8352538
- SCHEMBL14697562
- trans-N,4-Dimethoxy-N-methylcyclohexanecarboxamide
- 409346-72-1
- DTXSID001258959
-
- Inchi: 1S/C10H19NO3/c1-11(14-3)10(12)8-4-6-9(13-2)7-5-8/h8-9H,4-7H2,1-3H3
- InChI Key: KFOOJJKZYIONCR-UHFFFAOYSA-N
- SMILES: O(C)C1CCC(C(N(C)OC)=O)CC1
Computed Properties
- Exact Mass: 201.13649347g/mol
- Monoisotopic Mass: 201.13649347g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 0
- Hydrogen Bond Acceptor Count: 3
- Heavy Atom Count: 14
- Rotatable Bond Count: 3
- Complexity: 188
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- XLogP3: 0.9
- Topological Polar Surface Area: 38.8?2
Experimental Properties
- Density: 1.0±0.1 g/cm3
- Boiling Point: 255.5±50.0 °C at 760 mmHg
- Flash Point: 108.3±30.1 °C
- Vapor Pressure: 0.0±0.5 mmHg at 25°C
N,4-dimethoxy-N-methylcyclohexanecarboxamide Security Information
- Signal Word:warning
- Hazard Statement: H303May be harmful if swallowed+H313Skin contact may be harmful+H333Inhalation may be harmful to the body
- Warning Statement: P264+P280+P305+P351+P338+P337+P313
- Safety Instruction: H303+H313+H333
- Storage Condition:storage at -4℃ (1-2weeks), longer storage period at -20℃ (1-2years)
N,4-dimethoxy-N-methylcyclohexanecarboxamide Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| TRC | D461815-100mg |
N,4-Dimethoxy-N-methylcyclohexanecarboxamide |
409346-72-1 | 100mg |
$75.00 | 2023-05-18 | ||
| TRC | D461815-250mg |
N,4-Dimethoxy-N-methylcyclohexanecarboxamide |
409346-72-1 | 250mg |
$150.00 | 2023-05-18 | ||
| TRC | D461815-1g |
N,4-Dimethoxy-N-methylcyclohexanecarboxamide |
409346-72-1 | 1g |
$ 365.00 | 2022-06-05 | ||
| Biosynth | JRA34672-100 mg |
N,4-Dimethoxy-N-methylcyclohexanecarboxamide |
409346-72-1 | 100MG |
$139.00 | 2023-01-04 | ||
| Biosynth | JRA34672-250 mg |
N,4-Dimethoxy-N-methylcyclohexanecarboxamide |
409346-72-1 | 250MG |
$262.50 | 2023-01-04 | ||
| Biosynth | JRA34672-500 mg |
N,4-Dimethoxy-N-methylcyclohexanecarboxamide |
409346-72-1 | 500MG |
$420.00 | 2023-01-04 | ||
| Biosynth | JRA34672-1000 mg |
N,4-Dimethoxy-N-methylcyclohexanecarboxamide |
409346-72-1 | 1g |
$670.00 | 2023-01-04 | ||
| Biosynth | JRA34672-5000 mg |
N,4-Dimethoxy-N-methylcyclohexanecarboxamide |
409346-72-1 | 5g |
$2,200.00 | 2023-01-04 | ||
| TRC | D461815-1000mg |
N,4-Dimethoxy-N-methylcyclohexanecarboxamide |
409346-72-1 | 1g |
$442.00 | 2023-05-18 |
N,4-dimethoxy-N-methylcyclohexanecarboxamide Related Literature
-
Bo Wei,Zhenyu Liu,Chen Xie,Shu Yang,Wentao Tang,Aiwei Gu,Wing-Tak Wong,Ka-Leung Wong J. Mater. Chem. C, 2015,3, 12322-12327
-
Gloria Belén Ramírez-Rodríguez,José Manuel Delgado-López,Jaime Gómez-Morales CrystEngComm, 2013,15, 2206-2212
-
Domenico Lombardo,Gianmarco Munaò,Pietro Calandra,Luigi Pasqua,Maria Teresa Caccamo Phys. Chem. Chem. Phys., 2019,21, 11983-11991
-
Ross Harder,David C. Dunand,Ian McNulty Nanoscale, 2017,9, 5686-5693
-
Bin Han,Yasuo Shimizu,Gabriele Seguini,Celia Castro,Gérard Ben Assayag,Koji Inoue,Yasuyoshi Nagai,Sylvie Schamm-Chardon,Michele Perego RSC Adv., 2016,6, 3617-3622
Additional information on N,4-dimethoxy-N-methylcyclohexanecarboxamide
Comprehensive Overview of N,4-dimethoxy-N-methylcyclohexanecarboxamide (CAS No. 409346-72-1): Properties, Applications, and Industry Insights
N,4-dimethoxy-N-methylcyclohexanecarboxamide (CAS 409346-72-1) is a specialized organic compound gaining attention in pharmaceutical and agrochemical research due to its unique structural features. This cyclohexanecarboxamide derivative combines a dimethoxy substitution pattern with an N-methyl group, offering versatile reactivity for synthetic applications. Its molecular formula C11H21NO3 and moderate polarity make it valuable for designing bioactive molecules with improved solubility profiles.
Recent studies highlight the compound's potential as a building block in drug discovery, particularly for central nervous system (CNS) targets. The methoxy groups enhance blood-brain barrier penetration, while the amide linkage provides hydrogen-bonding capabilities crucial for target engagement. Researchers are exploring its utility in developing sustainable crop protection agents, aligning with the global push for eco-friendly agrochemicals—a trending topic in 2024 scientific forums.
The synthesis of 409346-72-1 typically involves selective methylation of the corresponding secondary amide, followed by etherification under controlled conditions. Analytical characterization via HPLC-MS and NMR spectroscopy confirms the presence of two distinct methoxy signals (δ 3.2-3.5 ppm) and the N-methyl proton (δ 2.8-3.0 ppm). These spectral features help distinguish it from similar compounds like N-methoxy-N-methylamides, a common search query among synthetic chemists.
In formulation science, the compound's logP value (~1.2) and melting point (92-94°C) make it suitable for lipid-based delivery systems. This addresses frequent industry questions about "improving API bioavailability"—a top search term in pharmaceutical development. Stability studies show excellent resistance to hydrolysis at pH 4-8, crucial for oral dosage forms.
Environmental considerations position N,4-dimethoxy-N-methylcyclohexanecarboxamide as a green chemistry candidate. Its biodegradation pathway involves demethylation to non-toxic metabolites, responding to growing regulatory demands for environmental risk assessment data—another hot search topic. The compound's low bioaccumulation potential (BCF < 100) further supports its sustainable profile.
Emerging applications include its use as a chiral auxiliary in asymmetric synthesis, where the cyclohexane ring induces stereoselectivity. Patent analyses reveal increasing references to CAS 409346-72-1 in catalytic process claims, particularly for organocatalysis—a field experiencing 30% annual growth in publications.
Quality control protocols emphasize HPLC purity assessment (typically ≥98%) and residual solvent monitoring. The compound's crystalline form shows excellent batch-to-batch reproducibility, addressing frequent manufacturer queries about "amide compound standardization." Storage recommendations suggest inert atmosphere protection below 25°C to prevent oxidative degradation.
Market intelligence indicates rising demand for 409346-72-1 in Asia-Pacific research hubs, correlating with increased investment in small molecule therapeutics. Custom synthesis inquiries often focus on isotope-labeled versions (e.g., 13C, 2H) for metabolic studies—a niche with 40% year-over-year growth in specialty chemical sectors.
Future research directions may explore the compound's supramolecular chemistry applications, particularly in host-guest systems where the methoxy groups could participate in molecular recognition. Computational modeling suggests potential as a hydrogen bond acceptor in crystal engineering, an area generating substantial academic interest based on publication metrics.
409346-72-1 (N,4-dimethoxy-N-methylcyclohexanecarboxamide) Related Products
- 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
- 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
- 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
- 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
- 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
- 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
- 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
- 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
- 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
- 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)